BackGenomma Lab Internacional, S.A.B. de C.V. Overview
Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V. Return on Equity

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) has a ROE of 14.47%, above the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

14.47%

Return on Equity

14.47%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) FAQ

The latest ROE for GNMLF is 14.47%. That is above the sector sector average of 11.64%. Investors often review this figure alongside Genomma Lab Internacional, S.A.B. de C.V.'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, GNMLF currently prints 14.47% for ROE, while the sector average sits near 11.64%. That is roughly 24.3% above the sector mean. Large gaps often invite a closer look at Genomma Lab Internacional, S.A.B. de C.V.'s growth, margins, and balance sheet.

Return on Equity shows how effectively Genomma Lab Internacional, S.A.B. de C.V. converts resources into returns. At 14.47%, GNMLF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GNMLF's ROE (14.47%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.